Results 21 to 30 of about 705,077 (307)

Implementing Clinical Audit in a Aesource-Limited Setting; Pediatricians Perceptions and Perspectives

BMC Health Services Research
Background Clinical audit (CA) is a quality improvement process aiming to systematically assess and improve patient care. It is among the seven pillars of clinical governance and an important tool for quality improvement in clinical practice.
Muaath Ahmed Mohammed, Rayan Sharief Shaibo, Salma Shakir Hassan, Elmuntasir Taha Mohamed Salah   +3 more
doaj   +1 more source

Incisors Extrusion with Clear Aligners Technique: A Finite Element Analysis Study

Applied Sciences, 2021
Since the low level of available evidence and the limited number of studies do not clarify whether clear aligners are a good option for extrusion, finite element (FE) analyses were performed to obtain more accurate biomechanical data about open-bite ...
Gabriele Rossini, Stefano Modica, Simone Parrini, Andrea Deregibus, Tommaso Castroflorio   +4 more
doaj   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng   +12 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Oxaliplatin-Associated Takotsubo Cardiomyopathy in a Patient with Metastatic Gastric Cancer: A Case Report

Case Reports in Oncology, 2023
We present the case of a 64-year-old female with stage IV gastric adenocarcinoma, pulmonary, and abdominal wall metastases, and no history of cardiovascular disease.
Luis Miguel Osorio-Toro, Diana Marcela Bonilla-Bonilla, Santiago Leandro Escobar-Dávila, Jhon Herney Quintana-Ospina, Luis Alvaro Melo-Burbano, Edith Norela Benitez-Escobar, Duván Arley Galindes-Casanova, Jorge Enrique Daza-Arana, Giovanna Patricia Rivas-Tafurt   +8 more
doaj   +1 more source

Special Numbers, Special Quaternions and Special Symbol Elements [PDF]

, 2018
{\small In this paper we define and we study properties of} $\left(l,1,p+2q,q\cdot l\right) -$ {\small numbers,} $\left(l,1,p+2q,q\cdot l\right) -$ {\small quaternions,} $\left(l,1,p+2q,q\cdot l\right) -$ {\small symbol elements. Finally, we obtain an algebraic structure with these elements.}
openaire   +2 more sources

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle, Kiersten Ricci, Kelly Blache, Rebecca A. Marsh, Adrienne M. Hammill, Elissa Engel   +5 more
wiley   +1 more source

Binocular versus standard therapy for amblyopia - effect on visual acuity, adherence, and patient or caregiver reported outcomes: protocol for a systematic review

Systematic Reviews
Background Traditionally, monocular interventions, like patching, have been the gold standard in amblyopia treatment. However, the current understanding that amblyopia is a binocular rather than monocular condition has inspired a surge in binocular ...
Ghada Aleinati, Maryam Alsamhan, Reema AlJassar, Sadan Alhajeri, Alaa AlAli   +4 more
doaj   +1 more source

Implementing Point-of-Care Newborn Screening for Sickle Cell Disease in Sudan: Cross-sectional Evidence from Khartoum State

Sudan Journal of Medical Sciences
Background: Sickle cell disease (SCD) is responsible for 50–90% of under-five mortality in sub-Saharan Africa. Delayed SCD detection beyond infancy prevents early comprehensive treatment and leads to the tragic progression of the disease.
Mohayra Elhassan, Sarah Abdaallah, Nihal Abdelmutalib, Tawadod Mahmmod, Ilham Omer   +4 more
doaj   +1 more source